Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus-Reference-Cited by-同舟云学术

Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus

Published:2017-09-28 Issue:5 Volume:103 Page:843-853
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Wadelius Mia¹,Eriksson Niclas²,Kreutz Reinhold³,Bondon-Guitton Emmanuelle⁴,Ibañez Luisa⁵,Carvajal Alfonso⁶,Lucena M. Isabel⁷,Sancho Ponce Esther⁸,Molokhia Mariam⁹,Martin Javier¹⁰,Axelsson Tomas¹¹,Kohnke Hugo¹,Yue Qun-Ying¹²,Magnusson Patrik K.E.¹³,Bengtsson Mats¹⁴,Hallberg Pär¹,

Affiliation:

1. Department of Medical Sciences; Clinical Pharmacology and Science for Life Laboratory, Uppsala University; Uppsala Sweden

2. Uppsala Clinical Research Center and Department of Medical Sciences; Uppsala University; Uppsala Sweden

3. Charité - Universitätsmedizin Berlin; Institut für Klinische Pharmakologie und Toxikologie; Berlin Germany

4. Service de Pharmacologie Médicale et Clinique; Centre Hospitalier Universitaire, Faculté de Médecine de l'Université de Toulouse; Toulouse France

5. Hospital Universitari Vall d'Hebron; Universitat Autònoma de Barcelona, Fundació Institut Català de Farmacologia; Barcelona Spain

6. Centro de Estudios sobre la Seguridad de los Medicamentos; Universidad de Valladolid; Valladolid Spain

7. S Farmacologia Clinica; Instituto de Investigación Biomedica de Málaga (IBIMA), H Universitario Virgen de la Victoria, Universidad de Málaga, CIBERehd; Madrid Spain

8. Servei d'Hematologia i Banc de Sang; Hospital General de Catalunya; Sant Cugat del Vallès Spain

9. NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London Department of Primary Care and Public Health Sciences; London UK

10. Instituto de Parasitologia y Biomedicina Lopez-Neyra, CSIC; Granada Spain

11. Department of Medical Sciences; Molecular Medicine and Science for Life Laboratory, Uppsala University; Uppsala Sweden

12. Medical Products Agency; Uppsala Sweden

13. Swedish Twin Registry; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet; Stockholm Sweden

14. Department of Immunology; Genetics and Pathology, Clinical Immunology, Uppsala University; Uppsala Sweden

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.805/fullpdf

Reference50 articles.

1. Idiosyncratic drug-induced agranulocytosis or acute neutropenia;Andres;Curr. Opin. Hematol.,2008

2. Drug-induced agranulocytosis in the Berlin case-control surveillance study;Huber;Eur. J. Clin. Pharmacol.,2014

3. Systematic review: agranulocytosis induced by nonchemotherapy drugs;Andersohn;Ann. Intern. Med.,2007

4. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis;Johnston;Expert Opin. Drug Metab. Toxicol.,2015

5. Non-chemotherapy drug-induced agranulocytosis;Garbe;Expert Opin. Drug Saf.,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety assessment of sulfasalazine: a pharmacovigilance study based on FAERS database;Frontiers in Pharmacology;2024-09-12

2. Genome-Wise Analysis for Drug Targeting;Advances in Genomics;2024

3. Nifedipine-induced agranulocytosis: A rare case report and literature review;Medicine: Case Reports and Study Protocols;2023-11

4. Sulfasalazine-Induced Delayed Hypersensitivity Reaction Presenting as Fever, Aseptic Meningitis, and Mesenteric Panniculitis in a Patient with Seronegative Arthritis;American Journal of Case Reports;2023-09-26

5. Clinical significance of tocilizumab-related neutropenia in patients with rheumatoid arthritis;Joint Bone Spine;2023-05